
Ind-Swift Laboratories (INDSWFTLAB) Share Price Touches 52-Week High of Rs 424.15
Updated: 29 Oct 2026 • 3:18 pm
Posted by:

Ind-Swift Laboratories Share Price was at Rs 406.65 at 3:07 PM IST on 29 October 2026, up Rs 27.20 or 7.17% from the previous close of Rs 379.45. The pharmaceutical stock touched a fresh 52-week high of Rs 424.15 during the session, and its market capitalisation stands at Rs 3,253.91 crore.
This Ind-Swift Laboratories Ltd. (INDSWFTLAB) stock update covers price action, fundamental analysis, sector benchmarks and peer comparison drawn from the latest Univest figures. The stock trades at a P/E ratio of 58.49 and a P/B ratio of 2.34, while ROE stands at 3.47% and ROCE at 4.00%. Readers following Ind-Swift Laboratories Share Price Today can use the sections below to see what the numbers show and which metrics are worth monitoring next.
Ind-Swift Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 406.65 |
| Previous Close | Rs 379.45 |
| Today's Move | +Rs 27.2 (+7.17%) |
| Open | Rs 380 |
| High | Rs 424.15 |
| Low | Rs 373.9 |
| Market Capitalisation | Rs 3,253.91 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 406.65 versus the previous close of Rs 379.45, a rise of 7.17%. The stock opened at Rs 380, reached a high of Rs 424.15 and touched a low of Rs 373.9.
Ind-Swift Laboratories Share Price Today reflects a sharp gain: the stock is at Rs 406.65, up 7.17%, after touching a fresh 52-week high of Rs 424.15. The current price is Rs 17.50 below that one-year high, so the stock has eased back from its peak but still sits well above the previous close of Rs 379.45.
The session opened at Rs 380.00, slightly above the previous close, and the day low was Rs 373.90. From that low to the 52-week high of Rs 424.15, the stock moved across a range of Rs 50.25 within a single session. The day change of Rs 27.20 is the figure behind the 7.17% gain.
The Ind-Swift Laboratories 52 Week High marks the highest price touched by the stock in the past year. All figures are as of 29 October 2026 at 3:07 PM IST and can change before the session ends. The next step is to see whether the fundamentals and valuation behind Ind-Swift Laboratories Share Price support the move.
Why Ind-Swift Laboratories Ltd. (INDSWFTLAB) May Be Moving Today
Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,253.91 crore |
| P/E Ratio | 58.49x |
| P/B Ratio | 2.34x |
| ROE | 3.47% |
| ROCE | 4% |
| EPS | Rs 6.49 |
| Book Value Per Share | Rs 162.43 |
| Dividend Yield | 0% |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 58.49x, P/B 2.34x, ROE 3.47%, ROCE 4%. These ratios show where the company stands today and are not a call to buy or sell.
Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3,253.91 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 58.49x, P/B at 2.34x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.49, book value per share of Rs 162.43, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.53x, median ROE of 11.23%, median ROCE of 13.1%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 58.49x |
| Benchmark Median P/E | 31.53x |
| Benchmark Average P/E | 46.15x |
| Benchmark P/E Range | 3.21x to 598.47x |
| Company P/B Ratio | 2.34x |
| Benchmark Median P/B | 2.75x |
| Company ROE | 3.47% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 4% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 3,253.91 crore |
| Benchmark Median Market Cap | Rs 711.9 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 58.49x, which is above the benchmark median of 31.53x, a difference of +85.51%. A P/E difference of this kind is a reference point rather than a recommendation.
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 3.47%, which is below the benchmark median of 11.23%, a difference of -69.1%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 4%, which is below the benchmark median of 13.1%, a difference of -69.47%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,394.97 | 11.24 | 1.24 | 9.81 | 10.68 |
| Solara Active Pharma Sciences Ltd. | SOLARA | 3,068.05 | 85.36 | 2.2 | -0.63 | 4.61 |
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 2,905.78 | 17.54 | 1.75 | 11.43 | 15.27 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,681.83 | 21.37 | 2.56 | 13.36 | 12.04 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,742.07 | 47.23 | 10.74 | 22.67 | 24.01 |
Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 58.49x compared with the displayed peer median of 21.37x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 3,253.91 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price is up 7.17% at Rs 406.65 against a previous close of Rs 379.45.
- The stock touched a fresh 52-week high of Rs 424.15 on 29 October 2026.
- The P/E ratio of 58.49 is above the same-industry median of 31.53.
- ROE of 3.47% and ROCE of 4.00% are below the industry medians of 11.23% and 13.10%.
- Market capitalisation of Rs 3,253.91 crore is above the industry median of Rs 711.90 crore.
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. is listed under the symbol INDSWFTLAB and operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry. Univest benchmarks it against 198 companies in the same industry, including Unichem Laboratories and Aarti Drugs.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
What is Ind-Swift Laboratories Share Price today?
Ans. Ind-Swift Laboratories Share Price was Rs 406.65 at 3:07 PM IST on 29 October 2026, up Rs 27.20 or 7.17% from the previous close of Rs 379.45, according to latest Univest data.
What is the Ind-Swift Laboratories 52 week high?
Ans. The stock touched a fresh 52-week high of Rs 424.15 today. The current price of Rs 406.65 is Rs 17.50 below that peak, and the day low so far is Rs 373.90 on the Ind-Swift Laboratories Share Price chart.
What is the Ind-Swift Laboratories market cap?
Ans. Ind-Swift Laboratories Market Cap is Rs 3,253.91 crore. Market capitalisation shows company size, not quality, and the median for the same Pharmaceuticals & Drugs industry benchmark is Rs 711.90 crore.
What is the P/E ratio of Ind-Swift Laboratories?
Ans. The P/E ratio is 58.49 against a same-industry median of 31.53 and an average of 46.15. That places the Ind-Swift Laboratories P/E 85.51% above the median across 169 companies with a P/E value.
What are the ROE and ROCE of Ind-Swift Laboratories?
Ans. ROE is 3.47% and ROCE is 4.00%. The industry medians are 11.23% and 13.10%, so both ratios sit below the benchmark, by 69.10% and 69.47% respectively, according to the latest Univest figures.
What are the EPS and book value of Ind-Swift Laboratories?
Ans. EPS is Rs 6.49 and book value per share is Rs 162.43. The P/B ratio of 2.34 compares with an industry median of 2.75, so it sits 14.91% below the median.
Does Ind-Swift Laboratories pay a dividend?
Ans. Dividend yield is 0%, so the latest Univest figures show no historical payout relative to the current price. Dividend yield is historical data and is not a promise of future payouts.
Which peers are compared with Ind-Swift Laboratories?
Ans. Five listed peers are compared: Unichem Laboratories, Solara Active Pharma Sciences, Advanced Enzyme Technologies, Aarti Drugs and Kwality Pharmaceuticals. Their P/E ratios range from 11.24 to 85.36 against 58.49 for Ind-Swift Laboratories.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Users can follow the live Ind-Swift Laboratories Share Price on Univest, along with fundamental ratios, 52-week levels and market insights for the stock. Univest also helps users compare the company with sector peers and revisit the Ind-Swift Laboratories Share Price Update as the session progresses.
Recent Articles

Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
18 November 2026

V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
18 November 2026

Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
18 November 2026

Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
18 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Cummins India Share Price Slips to Rs 4,005 Near Its 52-Week Low: Margins Squeezed by Commodity Costs While Price Hikes Take a Quarter to Flow Through
V2 Retail Share Price Plunges 15% to a 52-Week Low of Rs 122.73 Then Rebounds to Close at Rs 141.61: What We Know, What We Do Not and the Numbers to Watch
Infosys Share Price Falls to Rs 1,108.80, Down 25.4% in a Year: How India's IT Bellwether Lost a Quarter of Its Value and What Investors Should Check Next
Nifty Bank 62,000: Index Closes at 62,038.65 After a Record 62,442.20, Up 24% From Its April Low as SBI Surges While HDFC Bank and Axis Bank Lag
Mahanadi Coalfields IPO Opens 19 November: Rs 129 to Rs 136 Price Band, Rs 8,981 Crore Offer for Sale and a Coal India Unit Valued at About 8.4 Times Earnings

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





